BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25958927)

  • 1. The effects of mycophenolate mofetil on cytokines and their receptors in pulmonary arterial hypertension in rats.
    Zhang YF; Zheng Y
    Scand J Rheumatol; 2015; 44(5):412-5. PubMed ID: 25958927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
    Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
    J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q; Chen Y; Chen X; Zhang J; Lu W; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):360-4. PubMed ID: 25011512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil attenuates pulmonary arterial hypertension in rats.
    Suzuki C; Takahashi M; Morimoto H; Izawa A; Ise H; Hongo M; Hoshikawa Y; Ito T; Miyashita H; Kobayashi E; Shimada K; Ikeda U
    Biochem Biophys Res Commun; 2006 Oct; 349(2):781-8. PubMed ID: 16956581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects and mechanisms of mycophenolate mofetil on pulmonary arterial hypertension in rats.
    Zheng Y; Li M; Zhang Y; Shi X; Li L; Jin M
    Rheumatol Int; 2010 Jan; 30(3):341-8. PubMed ID: 19466418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil improves monocrotaline-induced pulmonary hypertension rat model.
    Lee H; Kim KC; Cho MS; Suh SH; Hong YM
    Pediatr Res; 2016 Jul; 80(1):119-27. PubMed ID: 26959484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.
    Ivy DD; McMurtry IF; Colvin K; Imamura M; Oka M; Lee DS; Gebb S; Jones PL
    Circulation; 2005 Jun; 111(22):2988-96. PubMed ID: 15927975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early treatment with hepatocyte growth factor improves pulmonary artery and right ventricular remodeling in rats with pulmonary artery hypertension by modulating cytokines expression].
    Wang X; Wang Y; Rong S; Ma H
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):427-32. PubMed ID: 25200042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeuchi K; Takeyoshi I; Morishita Y; Kobayashi E
    Transplantation; 2004 Jun; 77(11):1661-7. PubMed ID: 15201664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.
    Zhu R; Bi L; Kong H; Xie W; Hong Y; Wang H
    Int J Clin Exp Pathol; 2015; 8(10):12169-76. PubMed ID: 26722401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL; Guan RJ; Xu QH; Wu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocyte growth factor intervention on rats with pulmonary hypertension and effect of endothelial cell membrane microparticles].
    Liu Z; Zhang R; Yang Y; Wang J; He Z; Chen J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):433-6. PubMed ID: 25200043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.